journal article·2016-01-02Open access

Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?

Wenya Yu, Lu Wang, Na Han, Xiayan Zhang, Tanmay Mahapatra, Sanchita Mahapatra, Giridhar R. Babu, Weiming Tang, Roger Detels, Jinkou Zhao

Abstract

Antiretroviral drugs are being tried as candidates for the pre-exposure prophylaxis (PrEP) against HIV for a considerable period, due to their potential for immediate inhibition of viral replication. Discrepancies in the findings called for a critical review of the relevant efforts and their outcomes. A systematic literature search identified 143 eligible articles of which only 5 reported complete findings while another 11 were still on-going. Observed moderate efficacy and good safety profile seemed to identify PrEP as a promising step for minimizing the spread of HIV to relatively unaffected population and controlling the epidemic among high risk population groups. But the duration of this efficacy was found to depend heavily on the availability, adherence and other related issues like cost, political commitment, ethical consideration etc. To prevent potential cultural and behavioral modifications, proper pre-administration counseling also seemed critical for the success of PrEP as a cost-effective intervention with adequate coverage.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: HIV/AIDS Research and Interventions · HIV, Drug Use, Sexual Risk · Adolescent Sexual and Reproductive Health

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shijiazhuang Center for Disease Control and Prevention, Shijia Zhuang, China

National Center for AIDS/STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China

Institute of Clinical Molecular Biology, Peking University People’s Hospital, Beijing China

Mission Arogya Health and Information Technology Research Foundation, Kolkata, India

Public Health Foundation of India, Indian Institutes of Public Health, Hyderabad, Bengaluru Campus, Bengaluru, India

University of North Carolina, Project-China, Guangzhou, China

Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, USA

Impact Results and Evaluation Department, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland

References (100+)

Show source-provided references
1. 10.1371/journal.pone.000087510.1371/journal.pone.0000875 ↗
2. 10.1126/scitranslmed.300400610.1126/scitranslmed.3004006 ↗
3. 10.1097/QAD.0b013e32832b7dca10.1097/QAD.0b013e32832b7dca ↗
4. 10.1080/09540121.2010.50775010.1080/09540121.2010.507750 ↗
5. 10.1056/NEJMe120249210.1056/NEJMe1202492 ↗
6. 10.1056/NEJMoa110852410.1056/NEJMoa1108524 ↗
7. 10.1016/S0140-6736(07)60312-210.1016/S0140-6736(07)60312-2 ↗
8. 10.1086/37971410.1086/379714 ↗
9. 10.1097/00042560-199710010-0000610.1097/00042560-199710010-00006 ↗
10. Bartlett JG · Hopkins HIV Rep · 2000 · 12 · 8
11. 10.1086/42527310.1086/425273 ↗
12. 10.1016/0747-5632(94)00037-I10.1016/0747-5632(94)00037-I ↗
13. 10.1016/S0140-6736(11)60079-210.1016/S0140-6736(11)60079-2 ↗
14. 10.2105/AJPH.2003.03749910.2105/AJPH.2003.037499 ↗
15. 10.1016/j.amepre.2012.09.04510.1016/j.amepre.2012.09.045 ↗
16. 10.1521/aeap.2006.18.6.51810.1521/aeap.2006.18.6.518 ↗
17. 10.1056/NEJM19971120337210110.1056/NEJM199711203372101 ↗
18. 10.1136/bmj.332.7541.60510.1136/bmj.332.7541.605 ↗
19. 10.1097/00042560-199712010-0000710.1097/00042560-199712010-00007 ↗
20. 10.1086/31384910.1086/313849 ↗
21. 10.1016/S0140-6736(13)61127-710.1016/S0140-6736(13)61127-7 ↗
22. 10.1056/NEJMra02519510.1056/NEJMra025195 ↗
23. 10.1186/1742-7622-3-1610.1186/1742-7622-3-16 ↗
24. 10.1001/jama.292.2.22410.1001/jama.292.2.224 ↗
25. 10.1258/09564620677580920410.1258/095646206775809204 ↗
26. 10.1371/journal.pmed.005001610.1371/journal.pmed.0050016 ↗
27. Doherty T · Durban: Health Systems Trust · 2003
28. 10.1097/00002030-200102160-0001010.1097/00002030-200102160-00010 ↗
29. 10.1086/42840410.1086/428404 ↗
30. Fonner VA · Cochrane Database Syst Rev · 2012 · 9 · CD001224
31. 10.1258/ijsa.2009.00925510.1258/ijsa.2009.009255 ↗
32. 10.1097/00042560-200205010-0001410.1097/00042560-200205010-00014 ↗
33. 10.1126/scitranslmed.300039110.1126/scitranslmed.3000391 ↗
34. 10.1371/journal.pmed.005002810.1371/journal.pmed.0050028 ↗
35. 10.1016/S0140-6736(06)69158-710.1016/S0140-6736(06)69158-7 ↗
36. 10.1097/00002030-199909100-0002110.1097/00002030-199909100-00021 ↗
37. 10.1097/QAD.0b013e32801424bd10.1097/QAD.0b013e32801424bd ↗
38. 10.1126/science.111620410.1126/science.1116204 ↗
39. 10.1056/NEJMoa101120510.1056/NEJMoa1011205 ↗
40. 10.1016/S0140-6736(07)60313-410.1016/S0140-6736(07)60313-4 ↗
41. 10.1089/apc.1999.13.71710.1089/apc.1999.13.717 ↗
42. Hammond E · Antivir Ther · 2005 · 10 · L4
43. 10.1136/sti.2004.01399510.1136/sti.2004.013995 ↗
44. 10.1371/journal.pone.005501310.1371/journal.pone.0055013 ↗
45. 10.1101/cshperspect.a00741910.1101/cshperspect.a007419 ↗
46. 10.1097/00126334-200010010-0001410.1097/00126334-200010010-00014 ↗
47. Horvath T · Cochrane Database Syst Rev · 2009 · CD006734
48. 10.1348/135910704X2479810.1348/135910704X24798 ↗
49. 10.1016/S0749-3797(98)00037-310.1016/S0749-3797(98)00037-3 ↗
50. 10.1126/science.119374810.1126/science.1193748 ↗
51. 10.1186/1758-2652-13-2410.1186/1758-2652-13-24 ↗
52. 10.1086/51644210.1086/516442 ↗
53. 10.1080/0954012080261435810.1080/09540120802614358 ↗
54. 10.1001/archinte.166.1.4910.1001/archinte.166.1.49 ↗
55. 10.1097/QAI.0b013e31815e404110.1097/QAI.0b013e31815e4041 ↗
56. 10.1016/j.socscimed.2009.04.00210.1016/j.socscimed.2009.04.002 ↗
57. 10.1097/00002030-200403260-0001010.1097/00002030-200403260-00010 ↗
58. Mattick RP · 1997
59. 10.1093/infdis/jir18810.1093/infdis/jir188 ↗
60. 10.1056/NEJM19980806339061210.1056/NEJM199808063390612 ↗
61. Mondou E · Clin Infect Dis · 2005 · 41 · e4510.1086/432581 ↗
62. 10.1016/S0140-6736(10)60936-110.1016/S0140-6736(10)60936-1 ↗
63. 10.1038/sj.cr.729035410.1038/sj.cr.7290354 ↗
64. 10.1001/jama.293.7.81710.1001/jama.293.7.817 ↗
65. 10.1080/0954012070144909610.1080/09540120701449096 ↗
66. 10.1097/00002030-200203290-0001310.1097/00002030-200203290-00013 ↗
67. 10.1086/59709510.1086/597095 ↗
68. 10.1128/JVI.01073-0910.1128/JVI.01073-09 ↗
69. 10.1126/scitranslmed.300317410.1126/scitranslmed.3003174 ↗
70. 10.1080/0954012050045619310.1080/09540120500456193 ↗
71. 10.1016/S0277-9536(96)00258-410.1016/S0277-9536(96)00258-4 ↗
72. 10.1086/50874810.1086/508748 ↗
73. Pretorius C · PloS One · 2010 · 5 · e1364610.1371/journal.pone.0013646 ↗
74. 10.1371/journal.pmed.004023510.1371/journal.pmed.0040235 ↗
75. 10.1097/QAD.0b013e328332428310.1097/QAD.0b013e3283324283 ↗
76. Rueda S · Cochrane Database Syst Rev. · 2006 · CD001442
77. Rutenberg N · 2003
78. 10.1097/00126334-200404150-0001010.1097/00126334-200404150-00010 ↗
79. 10.1086/37830110.1086/378301 ↗
80. 10.1186/1742-4690-3-8710.1186/1742-4690-3-87 ↗
81. 10.1371/journal.pmed.002023410.1371/journal.pmed.0020234 ↗
82. Smith DK · Department of Health and Human Services. MMWR Recomm Rep · 2005 · 54 · 1
83. 10.1186/1742-4690-1-1610.1186/1742-4690-1-16 ↗
84. 10.1007/s11904-008-0027-z10.1007/s11904-008-0027-z ↗
85. 10.1097/00002030-200409240-0001010.1097/00002030-200409240-00010 ↗
86. 10.1086/50730610.1086/507306 ↗
87. 10.1097/00042560-200203010-0000110.1097/00042560-200203010-00001 ↗
88. 10.1097/QCO.0b013e328334e54d10.1097/QCO.0b013e328334e54d ↗
89. 10.1056/NEJMoa111071110.1056/NEJMoa1110711 ↗
90. Trial and failure. Only the most promising AIDS gels should reach large-scale trials · . Nature · 2007 · 446 · 1
91. 10.1034/j.1600-0684.2000.290318.x10.1034/j.1600-0684.2000.290318.x ↗
92. 10.1007/s11904-010-0062-410.1007/s11904-010-0062-4 ↗
93. 10.1097/QAI.0b013e3181e8efe410.1097/QAI.0b013e3181e8efe4 ↗
94. 10.2105/AJPH.92.3.34110.2105/AJPH.92.3.341 ↗
95. 10.1002/hep.2046410.1002/hep.20464 ↗
96. 10.1056/NEJMoa120261410.1056/NEJMoa1202614 ↗
97. 10.1097/00002030-200003100-0000310.1097/00002030-200003100-00003 ↗
98. Vissers DC · PLoS One · 2008 · 3 · e207710.1371/journal.pone.0002077 ↗
99. 10.1097/00126334-200402010-0001610.1097/00126334-200402010-00016 ↗
100. 10.1097/QAD.0b013e328338874210.1097/QAD.0b013e3283388742 ↗